SAB Biotherapeutics, Inc.
SABS
$3.70
-$0.05-1.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.43% | 11.18% | -12.89% | 1,840.64% | -55.54% |
| Total Receivables | 18.58% | 64.25% | 69.07% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.76% | 9.16% | 91.34% | -48.92% | 4.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.30% | 11.61% | -10.79% | 1,116.97% | -42.88% |
|
|
|||||
| Total Current Assets | -4.30% | 11.61% | -10.79% | 1,116.97% | -42.88% |
| Net Property, Plant & Equipment | -2.93% | 3.96% | -0.17% | -4.73% | -4.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.22% | -3.29% | 4,299.27% | -70.28% | -7.18% |
| Total Assets | -4.13% | 43.78% | -5.80% | 508.87% | -20.96% |
|
|
|||||
| Total Accounts Payable | 8.74% | 12.69% | 6.46% | 12.68% | 4.05% |
| Total Accrued Expenses | 33.83% | -18.19% | -3.88% | -3.41% | 17.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.38% | -3.23% | -3.73% | 2.61% | -10.58% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.81% | -7.76% | -1.04% | 1.09% | 10.61% |
|
|
|||||
| Total Current Liabilities | 18.81% | -7.76% | -1.04% | 1.09% | 10.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.50% | 5.06% | -3.84% | -4.70% | -4.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.17% | 8.56% | 136.60% | 20.26% | 46.32% |
| Total Liabilities | 10.38% | -0.44% | 16.01% | 1.44% | 8.38% |
|
|
|||||
| Common Stock & APIC | 2.96% | 35.50% | 1.20% | 68.47% | 0.40% |
| Retained Earnings | -17.33% | -17.02% | -17.93% | 32.58% | -7.82% |
| Treasury Stock & Other | -12.31% | -7.67% | 2.12% | 1.57% | 1.70% |
| Total Common Equity | -5.48% | 50.00% | -8.23% | 1,273.76% | -43.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | -5.48% | 50.00% | -8.23% | 1,273.76% | -43.87% |
| Total Preferred Equity | -- | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.48% | 50.00% | -8.23% | 1,273.76% | -43.87% |
|
|
|||||